AUS
NZ
UK
CA
USA
IND
Highlights:
- Sonic Healthcare (ASX:SHL) shares rise 4% to $27.30 after providing key updates during its AGM.
- The company reported $9 billion in FY24 revenue, with non-COVID-related sales up 16%.
- Sonic also raised its dividend by 2%, reflecting strong financial health and a solid outlook.
Shares of Sonic Healthcare Ltd (ASX:SHL), one of Australia's leading healthcare providers, are having a strong session, rising 4% to $27.30 per share. This positive movement comes after the company provided updates during its Annual General Meeting (AGM), where key comments from the company’s chairman, Mark Compton, highlighted Sonic’s resilience and long-term growth prospects. Despite the stock being down 16% year-to-date, trailing broader market indexes, Sonic's strategic direction and solid financial performance are providing some optimism for investors.
During its AGM, Sonic Healthcare provided a comprehensive overview of its financial health and future growth strategies. Chairman Mark Compton emphasized the company’s strong base business and its continued expansion across seven countries, underlining Sonic's broadening global footprint. This international diversification positions Sonic well in the evolving healthcare sector, which remains highly fragmented and competitive.
For the FY24 financial year, Sonic reported total revenue of $9 billion. While this figure is impressive, it was accompanied by a notable decline in net profit, which fell to $511 million. The decrease in profit was primarily due to a drop in COVID-19 testing revenues, as the pandemic’s effects continue to subside and vaccination rates increase globally. This fall in COVID-related sales was widely anticipated, and management had prepared the market for this shift.
While the drop in COVID testing revenue may raise concerns for some investors, Sonic’s underlying business remains robust. Excluding COVID-related revenue, Sonic reported a 16% year-over-year increase in sales. Notably, the company saw 600 basis points of growth in its “base business,” which includes its regular diagnostic, pathology, and medical services divisions. This signifies a strong return to pre-pandemic growth levels, further supported by the continued global expansion of its healthcare services.
In addition to reporting healthy revenue and profit growth, Sonic Healthcare also delivered positive news to its shareholders by increasing its dividend by 2% to $1.06 per share. This increase demonstrates the company’s commitment to rewarding its investors while maintaining a solid financial footing.
Sonic’s balance sheet also remains strong, with gearing levels below pre-pandemic levels. This indicates the company’s ability to manage its financial leverage effectively, even in an environment where global economic conditions are uncertain. For investors, the 4% share price rise following the AGM is a clear signal that the market is responding positively to Sonic's strategic direction and performance. While 2024 has been a challenging year so far for the stock, Sonic Healthcare's robust fundamentals and growth prospects could make it an appealing long-term investment.
